SF Bay Area patent attorney specialized in biologics and biotechnology.

Hands-on expertise in patent portfolio development, patent preparation & prosecution, freedom to operate, opinions, patent due diligence for acquisitions and licensing, offensive and defensive strategies for patent challenges.

Demonstrated track record of working effectively with scientific and business leadership, delivering quality, timely, and relevant patent guidance.

Experience leading in-house patent groups across wide-ranging indications, including Oncology, Vaccines, Rare Diseases, Biologics manufacturing, Immunoscience, and Biosimilars, in the US, Europe and Japan.

Representative projects: Ibrance, elranatamab, tanezumab, PD-1/PD-L1 antibodies, PCSK9 antibodies, gene therapy, CAR-T, antibody-drug conjugates, bispecific antibodies, antibody engineering and humanization, antibody libraries, Prevnar13.